GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $8.18 $12.25 Thursday, 18th Apr 2024 PHAT stock ended at $9.48. This is 3.27% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 3.81% from a day low at $9.46 to a day high of $9.82.
90 days $6.07 $12.25
52 weeks $6.07 $17.00

Historical Phathom Pharmaceuticals, Inc. prices

Date Open High Low Close Volume
2024-04-18 $9.68 $9.82 $9.46 $9.48 413 757
2024-04-17 $10.09 $10.27 $9.70 $9.80 424 049
2024-04-16 $10.00 $10.28 $9.88 $10.03 604 395
2024-04-15 $9.95 $10.31 $9.68 $10.02 566 740
2024-04-12 $10.54 $11.20 $9.97 $10.14 947 869
2024-04-11 $11.81 $12.08 $10.28 $10.47 1 045 795
2024-04-10 $11.71 $12.05 $11.24 $11.80 1 435 431
2024-04-09 $11.16 $12.25 $10.98 $12.05 1 271 934
2024-04-08 $11.10 $11.30 $10.88 $11.11 698 482
2024-04-05 $10.70 $11.07 $10.41 $11.03 1 506 354
2024-04-04 $10.02 $10.80 $9.86 $10.80 937 702
2024-04-03 $9.77 $10.00 $9.57 $9.86 446 395
2024-04-02 $10.38 $10.40 $9.55 $9.80 758 015
2024-04-01 $10.62 $11.11 $10.49 $10.60 722 956
2024-03-28 $11.14 $11.22 $10.42 $10.62 875 359
2024-03-27 $10.33 $11.14 $10.21 $11.05 751 057
2024-03-26 $10.69 $11.41 $10.43 $10.50 1 090 235
2024-03-25 $11.25 $11.35 $10.21 $10.45 1 144 458
2024-03-22 $9.11 $11.40 $9.11 $11.02 1 492 702
2024-03-21 $9.20 $9.86 $9.10 $9.16 481 277
2024-03-20 $8.61 $9.19 $8.53 $9.12 588 030
2024-03-19 $8.24 $8.81 $8.18 $8.62 481 708
2024-03-18 $8.53 $8.68 $8.12 $8.28 556 798
2024-03-15 $7.83 $8.51 $7.83 $8.49 939 105
2024-03-14 $7.95 $8.00 $7.55 $7.77 548 776
Click to get the best stock tips daily for free!

About Phathom Pharmaceuticals, Inc.

Phathom Pharmaceuticals. Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan, which is in Phase III clinical trials for the treatment of erosive gastroesophageal re... PHAT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT